Intelligence Platform
Patents
Browse 36 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8034334
Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative
granted patentUS 7815921
Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and
granted patentUS 7037904
Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing
expired patentUS 7008633
Local regional chemotherapy and radiotherapy using in situ hydrogel
expired patentUS 7005424
Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells
expired patentUS 6863885
Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent
expired patentUS 6653351
Adjuvant chemotherapy for anaplastic gliomas
expired patentUS 6426076
Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and r
expired patentUS 6423311
Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent
expired patentUS 6395712
Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy
expired patentUS 6261831
Ultra-wide band RF-enhanced chemotherapy for cancer treatmeat
expired patentUS 6103694
Method of decreasing radiation of radio-mimetic chemotherapy for hematopoietic pluripotent
expired